Literature DB >> 9429131

Overview of lamotrigine and the new antiepileptic drugs: the challenge.

J M Pellock1.   

Abstract

Lamotrigine, like all antiepileptic drugs, can be effective when used as monotherapy or adjunctive therapy. In general, adverse effects are reduced when monotherapy is employed. The most frequent adverse effect prompting withdrawal of lamotrigine is rash. This potentially life-threatening adverse effect occurs more frequently in children, is increased when a rapid dose titration schedule is employed, and is greater when lamotrigine, is prescribed in combination with valproate. The availability of lamotrigine and other antiepileptic drugs represents a major advance for the treatment of childhood epilepsy. The challenge in using all of the new antiepileptic drugs, including lamotrigine, is to balance the expected improved efficacy with the potentially serious adverse effects.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9429131     DOI: 10.1177/0883073897012001111

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  4 in total

1.  Population pharmacokinetics of lamotrigine in Indian epileptic patients.

Authors:  Surulivelrajan Mallaysamy; Martin G Johnson; Padma G M Rao; Thiyagu Rajakannan; Lokesh Bathala; Karthik Arumugam; Johan G C van Hasselt; Devarakonda Ramakrishna
Journal:  Eur J Clin Pharmacol       Date:  2012-06-02       Impact factor: 2.953

2.  Validated spectrofluorimetric method for the determination of lamotrigine in tablets and human plasma through derivatization with o-phthalaldehyde.

Authors:  Nahed M El-Enany; Dina T El-Sherbiny; Amina A Abdelal; Fathalla F Belal
Journal:  J Fluoresc       Date:  2009-11-27       Impact factor: 2.217

3.  Effect of lamotrigine on cerebral blood flow in patients with idiopathic generalised epilepsy.

Authors:  Eun Yeon Joo; Seung Bong Hong; Woo Suk Tae; Sun Jung Han; Dae Won Seo; Kyung-Han Lee; Mann Hyung Lee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-10       Impact factor: 9.236

4.  Correlation of the UGT1A4 gene polymorphism with serum concentration and therapeutic efficacy of lamotrigine in Han Chinese of Northern China.

Authors:  Ying Chang; Li-ya Yang; Meng-Chao Zhang; Song-Yan Liu
Journal:  Eur J Clin Pharmacol       Date:  2014-05-13       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.